Harbour Biomed

Harbour Biomed

Harbour Biomed

Harbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer
Type
B2b
Founded
2016
Raised
$160M
Follow us
Alexa global traffic share
Latest funding
$75,000,000
Venture capital (Series B) - 2020
Legend Capital Advantech Capital SK Holdings +5
$85,000,000
Venture capital (Series B) - 2018
Legend Capital Sovereign Wealth Funds Advantech Capital +3
Team Size
1–10
Employees
Location
Headquarters
$75,000,000 Venture capital (Series B)
ChinaMoneyNetwork

Chinese Biotech Firm Harbour BioMed Raises $75 Million In Series B+ Round

Xconomy

Harbour BioMed Tacks on $75M to Advance Broad Biologics Pipeline

MedCity News

Harbour BioMed raises $85M in Series B funding round

PE HUB

Harbour BioMed raises $85 mln

$85,000,000 Venture capital (Series B)
ChinaMoneyNetwork

GIC Leads $85M Series B Round In Chinese Biotech Firm Harbour BioMed

Venture capital (Series A)
FinSMEs , PE HUB

Harbour BioMed Closes Series A+ Financing

Funding
$50,000,000 Venture capital (Series A)
biospace , ENDPOINTS NEWS

New Global Upstart Acquires Harbour Biomed Antibodies Expands Boston Unit